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Abstract
Background: Genome-wide association studies (GWAS) have identified genetic factors in type 2 diabetes (T2D), mostly
among individuals of European ancestry. We tested whether previously identified T2D-associated single nucleotide
polymorphisms (SNPs) replicate and whether SNPs in regions near known T2D SNPs were associated with T2D within the
Singapore Chinese Health Study.
Methods: 2338 cases and 2339 T2D controls from the Singapore Chinese Health Study were genotyped for 507,509 SNPs.
Imputation extended the genotyped SNPs to 7,514,461 with high estimated certainty (r2.0.8). Replication of known index
SNP associations in T2D was attempted. Risk scores were computed as the sum of index risk alleles. SNPs in regions
6100 kb around each index were tested for associations with T2D in conditional fine-mapping analysis.
Results: Of 69 index SNPs, 20 were genotyped directly and genotypes at 35 others were well imputed. Among the 55 SNPs
with data, disease associations were replicated (at p,0.05) for 15 SNPs, while 32 more were directionally consistent with
previous reports. Risk score was a significant predictor with a 2.03 fold higher risk CI (1.69–2.44) of T2D comparing the
highest to lowest quintile of risk allele burden (p = 5.72610214). Two improved SNPs around index rs10923931 and 5 new
candidate SNPs around indices rs10965250 and rs1111875 passed simple Bonferroni corrections for significance in
conditional analysis. Nonetheless, only a small fraction (2.3% on the disease liability scale) of T2D burden in Singapore is
explained by these SNPs.
Conclusions: While diabetes risk in Singapore Chinese involves genetic variants, most disease risk remains unexplained.
Further genetic work is ongoing in the Singapore Chinese population to identify unique common variants not already seen
in earlier studies. However rapid increases in T2D risk have occurred in recent decades in this population, indicating that
dynamic environmental influences and possibly gene by environment interactions complicate the genetic architecture of
this disease.
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Introduction
T2D remains a very serious health threat in developed countries
and is becoming a major health threat in many under-developed
countries, particularly those with rapidly growing economies [1–
3]. Globally, T2D affected over 360 million people in 2011 [4] and
this number is projected to increase rapidly in upcoming years.
This rise in risk is paralleled by a rapidly increasing incidence of
obesity in many populations, a major risk factor for diabetes. In
addition, incidence may be propelled by an elevated genetic
susceptibility in some populations. Other risk factors include
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dietary patterns [5,6], sedentary lifestyle [7,8], psychosocial stress
[9–11], short sleep hours [12], and smoking [13–16].
Interestingly, the prevalence of T2D is much higher (approx-
imately 2-fold) in several Southeast or East Asian populations than
in populations of European-descent, even though most Asians
have a much lower average body mass index (BMI) and rates of
obesity [17–20]. The prevalence of T2D continues growing
rapidly in many Southeast Asian countries, including Singapore
[21]. Compared to populations of European ancestry, East Asians,
including Chinese and Japanese have been characterized as having
a higher proportion of abdominal and visceral fat deposits in the
presence of a BMI#25 kg/m2 [22,23], which is considered a
healthy BMI in populations of European descent. Also, diabetes
incidence in young to middle-aged people is disproportionately
higher in Southeast Asia than in the West [21]. This apparent
difference in susceptibility is recognized by the International
Federation of Diabetes, which has established lower BMI cutoffs
for overweight and obesity than are used for populations of
European-descent [24]. The apparently higher susceptibility
persists in individuals migrating from Southeast Asia to other
parts of the world and results in even higher levels of diabetes in
these populations when living in Western cultures [25–28].
It is well-known that T2D is heritable in many populations [29–
31] and has a familial recurrence risk ratio for first degree relatives
of approximately two [32,33]. In addition, numerous studies have
associated specific genetic variants with the risk of T2D. Several
notable associations were identified by linkage analysis and
candidate gene studies, and include PPARc [34], KCNJ11 [35],
WFS1 [36] and TCF7L2 [37]. The advent of large-scale genetic
studies searching the entire genome for common SNPs (frequen-
cy.5%) associated with diabetes has significantly increased the
number of SNPs associated with diabetes. Since 2007, genome-
wide association studies (GWAS) have reported at least 57
additional thoroughly replicated genetic susceptibility loci harbor-
ing common variants for T2D [38–57]. Most of these were novel
disease loci and contributed to a better understanding of diabetes
heritability. However, the effect sizes of these loci were small and
only a small proportion of the heritability of T2D was explained
[58]. Moreover, most of the SNP associations discovered by
GWAS were identified in European populations. However, Asian-
specific SNPs have been identified and several loci were first
identified by GWAS in Asians including KCNQ1 [40,59], UBE2E2
and C2CD4A-C2CD4B [48].
We investigated the reproducibility of single SNP associations in
a study of T2D among Singapore Chinese using both genotyped
and imputed alleles. Beyond investigating associations between
single variants and disease risk, it is important to consider the
combined effects of various loci on disease risk. In this report, we
used the National Human Genome Research Institute (NHGRI)
GWAS Catalog [60] to identify 59 single-nucleotide polymor-
phisms (SNPs) in 46 gene regions that have been associated with
T2D. In addition we interrogated regions near GWAS alleles to
search for additional or refined associations.
Research Design and Methods
Ethics Statement
This study has been approved by the institutional review boards
of the National University of Singapore, the University of
Southern California, the University of Minnesota, and the
University of Pittsburgh. Informed written consent to participate
in biomarker studies was obtained at time of specimen collection.
The institutional review boards approved this consent procedure.
Study Population
People of Chinese ancestry comprise the largest ethnic group in
Singapore and constitute 74.1% of Singapore’s resident popula-
tion [61]. The design of the Singapore Chinese Health Study has
been previously described [62]. Briefly the cohort is drawn from
permanent residents or citizens of Singapore aged 45–75 at study
entry, who reside in government-built housing estates (,86% of
Singapore residents live in such facilities). Migration out of
Singapore, especially among housing estates residents is negligible
(Department of Statistic, Singapore Ministry of Trade and
Industry, 1997). The study subjects are restricted to the two major
dialect groups of Chinese in Singapore: The Hokkiens, who
originated from southern Fujian Province, and the Cantonese,
who came from Guangdong Province (Both provinces are in south
eastern China. The gender dialect breakdown of the cohort is as
follows, 15,617 (24.7%) Hokkien men, 18,356 (29.0%) Hokkien
women, 12,342 (19.5%) Cantonese men, and 16,942 (26.8%)
Cantonese women.
Between April 1993 and December 1998, 63,257 individuals
completed an in-person interview that included questions on usual
diet, demographics, height and weight, use of tobacco, usual
physical activity, menstrual and reproductive history (women
only), medical history, and family history of cancer. A follow-up
telephone interview took place between 1999 and 2004 for 52,325
cohort members (83% of recruited cohort). Beginning in April
1994, a random 3% sample of cohort participants were asked to
provide blood or buccal cells, and spot urine samples. Eligibility
for this biospecimen subcohort was extended to all surviving
cohort participants starting in January 2000. By April 2005, all
surviving cohort subjects had been contacted for biospecimen
donation. Samples were obtained from 32,535 subjects, repre-
senting a consent rate of about 60%. The institutional review
boards at the National University of Singapore, the University of
Minnesota, and the University of Pittsburgh approved this study.
Utilizing resources of the Singapore Chinese Health Study, we
conducted a genome-wide association study (GWAS) for the risk of
developing diabetes that has a two staged design in which
approximately 1/2 of all participants in the study are genotyped
using a GWAS array with the remaining subjects genotyped as a
replication study of the top SNPs found in stage 1. This approach
follows the general principles of Satagopan et al [63] and Wang et
al [64]. Herein we report results from the first stage of this study
focusing on replication and fine-mapping of already-discovered
genetic variants.
Ascertainment of Type 2 Diabetes
For each study participant, the history of physician-diagnosed
diabetes was asked at a baseline interview administered by a
trained interviewer. Diabetes status was assessed again by the
following question asked during the first and second follow-up
telephone interviews: ‘‘Have you been told by a doctor that you
have diabetes (high blood sugar)?’’ If yes: ‘‘Please also tell me the
age at which you were first diagnosed’’. The prevalent diabetes
cases were those who reported a history of diabetes at the baseline
interview whereas the incident diabetes were those reporting the
initial diagnosis of diabetes that took place after the baseline
interview in either the follow-up I or follow-up II interview (,5.5
years between interviews). A validation study of the incident
diabetes mellitus cases used two different methods and was
reported in detail previously [65,66]. Based on a hospital-based
discharge summary database and a supplementary questionnaire
regarding symptoms, diagnostic tests and hyperglycemic therapy
during a telephone interview we observed a positive predictive
value of 99% [66]. In other words, the self-reported history of
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diabetes was a highly reliable measure of diabetes status of the
study population.
Eligible Study Subjects
The cohort participants who did not report a history of diabetes
at baseline interview and donated blood samples were eligible for
the present study. We excluded subjects with prevalent diabetes at
the baseline interview (n= 2,080) or did not provide blood samples
(n = 36,245). The present study was based on the remaining
24,932 subjects. Among them, we identified 1,284 incident
diabetes cases during the follow-up I interview in 2000–2005,
and an additional 1,343 incident diabetes cases during the follow-
up II interview in 2006–2011. For each incident diabetes case, one
control subject was randomly selected among the subjects that
provided blood samples but did not have a history of diabetes.
Controls were matched to the index cases on gender, dialect group
(Cantonese or Hokkien), age at baseline interview (63 years), year
of baseline interview (62 years), and date of blood draw (66
months). In addition, the selected controls were screened for the
presence of undiagnosed T2D. The criterion for undiagnosed
diabetes was the hemoglobin A1c (HbA1c)$6.0%. All matched
controls with HbA1c$6.0% were ineligible for the study and a
replacement control with the same matching criteria was
randomly chosen among the remaining eligible subjects. Blood
for HbA1c analysis was collected in EDTA (ethylenediaminetet-
raacetic acid) tubes. Red-blood cells (RBCs) were isolated from
whole blood and frozen until analysis was performed at University
of Minnesota, a Clinical Laboratory Improvement Amendments
(CLIA)-certified laboratory. HbA1c was measured with a dedicat-
ed HPLC instrument in our laboratory which serves as a reference
laboratory for this assay. The instrument, a TOSOH HPLC,
utilizes ion-exchange chromatography (Tosoh A1c 2.2 Plus
HPLC, Tosoh Medics, Inc., Foster City, CA). This instrumenta-
tion is also referred to as the Tosoh G7/G8 HPLC Glycohe-
moglobin Analyzer (Tosoh Medics, Inc., San Francisco,
California). A small red blood cell sample was automatically
hemolyzed prior to injection onto the column. The labile fraction
is separated on-line as a distinct peak and excluded from the
calculation of % HbA1c. The hemoglobin fractions (A1a, A1b, F,
Labile A1c, Stable A1c, A0 and Hb variants) are separated by a
buffer gradient of increasing ionic strength. The Tosoh 2.2+ was
calibrated daily using 2 calibrators (2-point calibration) standard-
ized to a reference system and the percentage of HbA1c was
calculated based on this system. Using the standards developed in
the National Glycohemoglobin Standardization Program, this
method was calibrated to the reference range of 4.3%–6.0% and
had a laboratory coefficient of variation range 1.4%–1.9% [67].
Genotype Analysis and Quality Control
Peripheral blood samples from 2615 incident diabetes cases and
2615 matched controls were selected for DNA extraction in stage
1. The DNA extraction was conducted at the Molecular
Epidemiology and Biomarker Research Laboratory at the
University of Minnesota (approximately 2/3rds of the samples)
or the Genome Institute of Singapore (approximately 1/3rd of the
samples) using the Qiagen method. DNA concentrations were
measured by the PicoGreen and Nanodrop methods and prepared
for genotype analysis.
Stage 1 genotyping was performed at the Genome Institute of
Singapore according to the manufacturer’s recommendations
using an Affymetrix ASI (Asian) Axiom array. Genotype calling
was performed by the Affymetrix Corporation. A standard series
of QC steps were followed in order to identify SNPs in case and
control samples for genetic association analyses. Starting with
510,584 SNPs provided for 4,918 callable study samples, we
excluded samples with SNP call rates of less than 98 percent
(n = 22) and SNPs (n = 3,075) with call rates less than 98 percent,
leaving 507,509 SNPs.
We estimated relatedness between pairs of samples as the
expected number of alleles shared identically by descent, rij, using
PLINK [68]. We dropped two pairs of unintended duplicate
samples that were discovered to have rij close to one; we also
dropped samples that appeared to be closely related (rij..2) to
more than one other sample in the study and one of each
remaining pair of samples with rij..2 (n = 180 total including the
duplicates). We compared reported sex of each sample to sex as
inferred on the basis of X chromosome heterozygosity, dropping
29 uncertain or conflicting samples. We computed principal
components of the genotype matrix and dropped 9 individuals
who were more than 5 standard deviations from the mean on any
of the first 4 principal components. One additional sample was
dropped because of missing covariate information. A total of 4,677
samples (2338 cases and 2339 controls) remained after QC
analysis.
Statistical Analysis
Characteristics of the cohort were compared between diabetes
cases and controls. Two sample t-tests were used to compare the
mean differences for variables with normal distributions. The
Wilcoxon rank sum test was used to compare median differences
for variables with skewed distributions. Pearson x2 was used to test
if the frequency distributions for categorical variables were
different between diabetes cases and controls.
For genotype imputation, we first mapped genetic positions of
our GWAS data to NCBI build37 using UCSC Genome Browser
liftOver [69]. 14,032 (,3%) SNPs failed to be mapped to NCBI
build37. The Segmented Haplotype Estimation and Imputation
tool (SHAPEIT) [70] was then used to phase the remaining
493,477 SNPs. We applied 1000 Genomes Project Phase I data
‘‘version 3’’ [71] as the reference panel, which contained 1092
individuals of various ethnicities (246 Africans, 181 African
Americans, 286 East Asians and 379 Europeans) with
36,648,992 SNPs. IMPUTE2 [72] was run to perform the
imputation, which extended our total SNPs to be 36,617,842.
After filtering out SNPs imputed to be monomorphic or with
estimated r2,0.8, there were 7,514,461 imputed or genotyped
SNPs for association analysis.
For this report, we selected 83 SNPs associated with T2D
summarized by NHGRI GWAS Catalog [60] and significantly
associated with diabetes risk at a well-recognized criteria for
genome-wide significance (p#561028). Among these, one SNP
was neither genotyped nor imputed in our data, 12 SNPs were
poorly imputed with estimated certainty r2,0.8, and one
genotyped SNP had rare minor allele frequency (MAF) less than
0.008. Additionally, 14 of the GWAS SNPs were found to be in
LD with 11 other GWAS SNPs with estimated pairwise r2.0.75
using our genotyped and imputed data. After excluding these 28
SNPs, the logistic regression method was used to analyze the single
SNP associations of the remaining 55 GWAS-implicated SNPs
with diabetes case-control status after adjusting for age, sex,
dialect, and first 10 principal components. The logistic regressions
utilized the observed genotyped or expected imputed allele counts
as the explanatory variable of interest.
The 55 SNPs from the GWAS catalog are called ‘‘index SNPs’’
in the fine-mapping analysis. Among these 55 SNPs, one SNP had
no reported risk allele in the GWAS-catalog and the original
papers. Thus, it was not included in the genetic risk score analysis
described below. Power calculations were conducted using Quanto
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[73] for the 55 SNPs based on the risk allele frequencies in our
4,677 study subjects using a significance level of 0.05 and the odds
ratio reported by the GWAS-catalog.
After single SNP association analysis, we constructed genetic
risk scores based on genotyped only, imputed only, and both
genotyped and imputed known diabetes SNPs combined by
adding the observed or expected number of risk alleles for each
study participant according to the risk allele reported in GWAS
Catalog. The association between the genetic risk score and
diabetes mellitus status was assessed using logistic regression
adjusting for the same covariates as in the previous single SNP
association analysis.
For fine-mapping analysis, regions 100 kb up and down stream
of each index SNP were obtained from the combination of
genotyped and imputed data. As before, logistic regression was
used to test significant associations between the observed or
expected allele counts (log additive model) for each SNP and
disease status. Additionally, conditional analysis was performed for
each SNP in a GWAS-indicated region by adjusting for the index
SNP of that region in addition to the other covariates. Such
conditional analysis attempts to refine SNP associations and search
for stronger signals than index SNPs. Bonferroni adjustment was
used to set the significance level for SNP association tests as 0.05/
number of SNPs in each region. Based on fine-mapping results
and following the approach of Chen et al [74], we attempted to
define two types of SNPs: 1. ‘‘Improved SNPs’’, i.e. SNPs in LD (in
the original populations) with index signals (r2$0.5) but with
stronger results in the present GWAS than the index signals; 2.
‘‘New SNPs’’ i.e. SNPs with significant associations, but which
were not in close LD with index signals (r2,0.5) that may reflect
new associations in regions already known to be involved in
disease risk. Next, fine-mapping results were used to improve the
genetic score by substituting index SNPs with improved SNPs and
adding new SNPs into the score. The risk allele and effect sizes of
improved SNPs as well as new SNPs were defined based on our
fine-mapping results.
Finally, Genome-wide Complex Trait Analysis (GCTA) was
performed to estimate the proportion of disease variance (using a
liability model) that is explained by GWAS reported diabetes SNPs
as well as any newly identified SNPs from the fine-mapping
analysis [75].
Results
Characteristics of subjects in this study are presented in Table 1.
The mean age and distributions of female gender, dialect group
and smoking status or duration of smoking in cases were
comparable with those in controls. Compared to controls, cases
had a higher BMI (p,0.0001) and lower level of education
(p = 0.004). More controls had weekly engagement of physical
activities than cases (p = 0.043).
Among 55 potentially diabetes-related SNPs identified from the
NHLBI GWAS Catalog, 20 SNPs were genotyped and 35 SNPs
were imputed with r2.0.8. Here r2 was estimated as sample
variance (over all individuals in the study) of the expected allele
count (i.e. the imputed values) divided by the theoretical value,
2p(1-p), of the variance of the count for a SNP in Hardy Weinberg
equilibrium where p is the estimated frequency of the allele [76].
Based upon the risk allele frequency seen in our sample from the
Singapore Chinese Health Study and on the reported odds ratio
and risk allele from the GWAS catalog (for 54 SNPs with this
information available) we had an average of 62.8 percent power to
replicate true associations at a 5 percent significance level. Of the
54 SNPs with known risk alleles we found that 15 (27.8%) had
significant associations (p,0.05) in the same direction as those
reported with diabetes risk after adjusting for age, sex, dialect and
10 principal components (Table S1). Among the remaining 39
non-significant associations a total of 32 (82.1%) of the associations
indicated that the same allele was associated with increased risk as
listed in the GWAS catalog. Quantile-quantile (QQ) plots
(Figure 1) of the p-values for association of the 55 SNPs showed
considerable deviation from the distribution expected under the
null hypothesis, further indicating that these 55 index SNPs
included strong signals for diabetes risk in the Singapore Chinese
population.
Non-replication of known or putative disease SNPs may be a
result of differing LD patterns in Singapore Chinese relative to the
original GWAS populations so that index SNPs might not be
sufficiently correlated with the underlying biological causal variant
in Singapore Chinese. In order to try to identify better genetic
markers of risk in Singapore Chinese, we conducted fine-mapping
analysis across all risk regions (6100 kb of index SNP), using
genotyped SNPs on the Affymetrix array and imputed SNPs seen
in the 1000 Genomes data (see Methods).
We searched for improved candidate SNPs from among those
1000 genome SNPs that were found to be in high LD (r2$0.5) in
the original GWAS population, as well as for novel SNPs not
highly correlated with the index within the reported regions. After
applying a Bonferroni correction for the number of SNPs tested in
each region, we found two improved signals (both Bonferroni
adjusted p-values = 0.033, Figure 2) for rs2453051 and rs2493413
having r2 = 1 (in Europeans based on 1000 genomes pilot data)
with index SNP rs10923931. The two improved signals and the
index SNP were located in the NOTCH2 gene on chromosome 1.
Additionally, we found five novel independent associations in 2
regions. Four correlated (pairwise r2.0.97) novel SNPs
(rs10757282, rs7019778, rs10757283, and rs7019437) were found
around index rs10965250 (Bonferroni adjusted p-value,0.044 for
all, Figure 2). These SNPs were on chromosome 9 and near the
N2B-AS1 gene. SNP rs10757282 had the most significant
association (Bonferroni adjusted p-value = 0.028). Another three
significant associations (rs11187139, rs10882102 and rs78216286)
were found around index rs1111875 (Bonferroni adjusted p-
value,0.040 for all, Figure 2), however two of these SNPs
rs11187139 and rs10882102 were on closer inspection found to be
correlated with another nearby index SNP rs5015480 (r2.0.84),
thus are not included in further analysis. The remaining SNP
rs78216286 was on chromosome 10 near the KIF11 gene. SNP
rs78216286 is included in the following risk score analysis. These
novel signals may indicate additional causal variants unidentified
in the original GWAS.
The cumulative effect of all T2D risk variants was tested using
unweighted counts of all diabetes risk SNPs. We did association
analysis using a risk score comprised of four sets of risk alleles: 1)
19 genotyped SNPs; 2) 35 imputed SNPs; 3) 54 SNPs (genotyped
and imputed); 4) original 54 SNPs with rs10923931 replaced by
rs2453051, and including 2 new independent SNPs identified from
fine-mapping analysis (rs10757282, and rs78216286) (Table 2).
Using the 54 index SNPs from the GWAS catalog, the risk per
allele was 1.049 (95% confidence interval (CI) 1.036–1.062;
p = 2.93610214). Individuals in the highest quintile of the risk
allele distribution were at 2.0-fold greater risk (p = 5.72610214) of
T2D compared to individuals in the lowest quintile (Table 2). In
single SNP analysis for the genotyped SNPs the mean odds ratio in
the Singapore data was 1.100 while for the imputed SNPs the
mean odds ratio was 1.058. In the risk score using genotyped SNPs
the estimated OR per allele was 1.073 (1.049–1.097;
p = 4.30610210). For the risk score with only imputed SNPs the
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odds ratio per allele was OR=1.048 (95% CI: 1.031–1.065;
p = 3.1961028). When the three new or improved SNPs were
included in the risk score the association with T2D was slightly
strengthened (per allele OR=1.053; 95% CI 1.040–1.066;
p = 6.68610216). Compared to individuals in the lowest quintile
of this risk score, those in the highest quintile had a 2.1 times
greater risk of the disease (p = 2.09610216). Interestingly we noted
no evidence that the per allele odds ratios were different
depending upon whether the index SNP was reported in GWAS
of either a European or Asian population (mean OR in the
Singapore sample was 1.063 for the 19 SNPs reported from
GWAS in Asian populations versus 1.078 for the 35 SNPs
reported from GWAS in European populations, Table S1).
Finally, we estimated the proportion of variance of diabetes risk
(on the liability scale) explained by these SNPs using the GCTA
program [77]. We assumed the prevalence of diabetes among the
population to be 0.08 based on International Diabetes Federation
report [4] and found that the 55 GWAS-reported diabetes SNPs
explained 2.3% of disease liability variance after adjusting for age,
sex, dialect and first 10 principal components (p = 0.007). After
adding two novel SNPs from our fine-mapping analysis, the entire
57 SNPs were again estimated to explain 2.3% variance of the
liability of diabetes in the sample (p = 0.007).
Discussion
Replication and fine mapping of GWAS index disease
associations in additional populations is useful for defining the
relevancy of associations discovered in one population to other
ethnic groups. In addition, studies of ethnically diverse groups
contribute to the localization of associations and the discovery of
new disease risk alleles in previously identified regions [74].
We were able to replicate disease associations (p,0.05) for 15 of
54 SNPs considered validated by prior studies. Of the 39 SNPs
that were not replicated at p,0.05, the average power based on
the GWAS-reported OR and Singapore Chinese risk allele
Table 1. Characteristics of subjects comparing T2D cases and controls.
Cases (n=2338) Controls (n =2339) p
Anthropometrics
Age [yrs]* 55.3 (7.2) 55.2 (7.1) 0.575
Females` 1227 (52.5) 1247 (53.3) 0.568
BMI [kg/m2]* 24.6 (3.4) 22.7 (3.1) ,0.0001
Physical activity weekly (%)` 32.7 35.5 0.043
Food energy intake [kcal/day]* 1619 (589) 1578 (547) 0.014
Smoking History
non-smokers`1 1579 (69.3) 1643 (71.9)
Former smokers`1 285 (12.5) 258 (11.3) 0.143
Current smokers`1 415 (18.2) 383 (16.8)
Years of smoking (among current and former smokers) { 1 25 (15, 35) 25 (15, 35) 0.808
Education levels
No education` 543 (23.2) 483 (20.7)
Primary school education` 1074 (45.9) 1033 (44.2) 0.004
Secondary school education or more` 721 (30.8) 823 (35.2)
Dialect group
Cantonese` 1166 (49.9) 1165 (49.8) 0.965
Hokkien` 1172 (50.1) 1174 (50.2)
*Variables are presented as mean (standard deviation). Two-sample independent t-test is used to test the mean differences between cases and controls.
{Variables are not normally distributed and are presented as median (25th, 75th percentiles). Wilcoxon rank-sum test is used to compare the median differences between
cases and controls.
`Categorical variables are presented as frequencies (%).x2 test is used to test whether the distribution between cases and controls is different.
1Variables have 59 cases and 55 controls missing.
doi:10.1371/journal.pone.0087762.t001
Figure 1. QQ-plot of 55 T2D SNPs reported by GWAS-catalog.
Observed distribution of2log P-values were compared to the expected
(null) distribution.
doi:10.1371/journal.pone.0087762.g001
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Figure 2. 2log P -plots of the improved and novel T2D signals around index SNPs: rs10923931, rs10965250 and rs1111875 found
by fine-mapping analysis. 2Log P-value for risk-associated allele from the logistic regression model adjusted for age, sex, dialect and global
ancestry (the first 10 principal components). Pairwise correlations (r2) in the 1000 Genomes Asian population are shown in relation to markers
identified through fine-mapping in our sample. Squares denote genotyped SNPs; circles, imputed SNPs. Gray squares and circles denote that r2
cannot be estimated (not in 1000 Genomes). Red arrows and diamond denote the index SNP. Blue arrows denote the novel signal. The plots were
generated using LocusZoom [86].
doi:10.1371/journal.pone.0087762.g002
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Table 2. Summary risk scores in association with T2D.
2,338 cases, 2,339 controls
Summary score of genotyped index markers (19 markers)
Mean risk score of cases (range)/controls (range) 14.8 (7.0–25.0)/14.3 (6.0–25.0)
Per allele OR 1.073 (1.049–1.097)
Ptrend 4.301610
210
Quintile OR (95% CI) Q1 1.00 (ref)
Q2 1.26 (1.03–1.53)
Q3 1.40 (1.19–1.65)
Q4 1.28 (1.04–1.56)
Q5 1.68 (1.41–1.99)
Summary score of well imputed index markers (35 markers)
Mean risk score of cases (range)/controls (range) 37.1 (24.3–48.8)/36.5 (21.5–47.8)
Per allele OR 1.048 (1.031–1.065)
Ptrend 3.193610
28
Quintile OR (95% CI) Q1 1.00 (ref)
Q2 1.19 (0.99–1.43)
Q3 1.36 (1.14–1.64)
Q4 1.32 (1.10–1.59)
Q5 1.66 (1.38–1.99)
Summary score of all imputed index markers (44 markers)
Mean risk score of cases (range)/controls (range) 49.4 (36.3–61.7)/48.7 (33.9–60.9)
Per allele OR 1.048 (1.032–1.064)
Ptrend 1.172610
29
Quintile OR (95% CI) Q1 1.00 (ref)
Q2 1.04 (0.87–1.25)
Q3 1.27 (1.06–1.52)
Q4 1.37 (1.14–1.64)
Q5 1.57 (1.31–1.89)
Summary score of genotyped and well imputed index markers (54 markers)
Mean risk score of cases (range)/controls (range) 51.9 (36.8–66.9)/50.8 (33.5–70.5)
Per allele OR 1.049 (1.036–1.062)
Ptrend 2.931610
214
Quintile OR (95% CI) Q1 1.00 (ref)
Q2 1.39 (1.16–1.67)
Q3 1.34 (1.12–1.61)
Q4 1.57 (1.31–1.89)
Q5 2.03 (1.69–2.44)
Summary score of all index markers (63 markers)
Mean risk score of cases (range)/controls (range) 64.2 (47.3–80.4)/63.0 (45.9–80.1)
Per allele OR 1.050 (1.037–1.062)
Ptrend 1.147610
215
Quintile OR (95% CI) Q1 1.00 (ref)
Q2 1.26 (1.05–1.52)
Q3 1.23 (1.02–1.48)
Q4 1.57 (1.31–1.89)
Q5 2.03 (1.69–2.44)
Summary score of genotyped, well imputed index markers and 2 novel marker (56 markers)
Mean risk score of cases (range)/controls (range) 53.3 (38.3–68.2)/52.2 (36.1–70.5)
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frequency was 58.5 percent (Table S1, Figure S1) compared to
73.8 percent for the replicated SNPs. Our failure to replicate more
known associations, despite reasonable power to do so, may be due
to several reasons; it is possible that the odds ratios estimated for
the reported risk alleles were biased upwards by a ‘‘winner’s curse’’
phenomenon [78] thus causing an overestimation of statistical
power for replication. Our risk score analysis using the sum of all
54 (both genotyped and well imputed) GWAS-significant risk
alleles as a predictor of T2D risk in the Singapore Chinese Health
Study population, while highly significant statistically (p,10213),
showed per-allele ORs that are smaller on average (1.05) than the
mean (1.16) of the published ORs for these alleles or of the mean
(1.07) of the single SNP ORs estimated in this study. This appears
to be indicating either a sub-multiplicative effect of the SNPs in
aggregate and/or reflecting a slight negative correlation
(r =20.25) between risk allele frequency and OR evident in
Table S1. Additionally including nine poorly imputed SNPs into
the risk score did not significantly influence previous results (per-
allele ORs= 1.05, 95% CI: 1.04–1.06, p= 1.147610216, Table
S1).
The attenuation of effect between the reported ORs and the
ORs estimated here may also be due to differences in LD between
the initial GWAS populations and the Singapore Chinese so that
the correlation between index SNP and underlying causal variant
is lower. In fine mapping analysis we found an improved signal for
two SNPs (rs2453051 and rs2493413) that were in high LD with
the index SNP rs10923931 in the original (European) reporting
population but not in our study (r2 = .426). We also found five
novel candidate SNPs (rs10757282, rs7019778, rs10757283,
rs7019437, rs78216286) near two index SNPs, rs10965250 and
rs1111875, which passed our criteria for significance but were not
among the ones in LD with the original index SNPs in the
reporting populations; SNP rs10965250 was reported in European
population [47], and rs1111875 was reported in both European
and Japanese populations [38,79–81]. While these results may be
novel associations, i.e. new signals in a region already implicated in
GWAS studies, further replication (as in stage 2 of this two-stage
GWAS study) will be needed before these will be well-accepted risk
alleles.
It appears that our efforts to impute ungenotyped SNPs
implemented by the programs SHAPEIT [70] and IMPUTE2
[72] were largely successful; as shown in the Results section we
were able to impute with a high degree of estimated certainty for
the large majority of ungenotyped risk alleles. We do note that the
fraction of replicated risk alleles among imputed SNPs (6 of 35,
17.1%, Table S1) were smaller compared to the directly
genotyped ones (9 of 19, 47.4%). This is partly explained by
allele frequency and odds ratio differences which lead to somewhat
decreased power (60.6% versus vs. 66.7%, Table S1) for imputed
and genotyped SNPs respectively. In addition imputation involves
some loss of power, governed by the r2 between the imputed and
true genotypes [82]. Nevertheless the score involving only imputed
SNPs was a highly significant predictor of diabetes risk
(p = 3.1961028).
More generally our findings indicate that only a very small
fraction of T2D in Singapore Chinese can be explained by the
SNPs in the risk regions examined to date. The rapid increase in
T2D in Singapore and in other Asian and South East Asian
communities [4,21,22] strongly indicate environmental factors are
at play, yet susceptibility to these factors (notably BMI) appears to
differ greatly by racial/ethnic group [83–85]. Understanding the
interplay between genes and lifestyle-related risk factors that could
produce such notable racial/ethnic disparities would seem to be
among the most important needs in diabetes epidemiology. A
separate report on genetic interactions between individual risk
SNPs, genetic scores, and lifestyle or other ‘‘environmental’’
variables is under development using these data. It is clear also that
very large sample sizes are needed to establish new T2D risk alleles
since it is evident that each one plays a small role by itself even
when strongly significantly predictive in composite (as in our risk
score analyses). Our ability to extend through imputation the set of
SNPs used in the present study (based on the Affymetrix Axiom
ASI array) to over 7 million SNPs with good reliability and
demonstrated predictive ability means that this study can
Table 2. Cont.
Summary score of genotyped, well imputed index markers and 2 novel marker (56 markers)
Per allele OR 1.053 (1.040–1.066)
Ptrend 6.679610
216
Quintile OR (95% CI) Q1 1.00 (ref)
Q2 1.27 (1.06–1.52)
Q3 1.25 (1.04–1.50)
Q4 1.60 (1.33–1.92)
Q5 2.10 (1.74–2.52)
Summary score of all index markers and 2 novel marker (65 markers)
Mean risk score of cases (range)/controls (range) 65.6 (49.9–81.4)/64.4 (48.9–80.1)
Per allele OR 1.053 (1.040–1.065)
Ptrend 2.684610
217
Quintile OR (95% CI) Q1 1.00 (ref)
Q2 1.30 (1.09–1.57)
Q3 1.36 (1.13–1.63)
Q4 1.58 (1.31–1.90)
Q5 2.18 (1.81–2.62)
doi:10.1371/journal.pone.0087762.t002
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contribute to the very large scale highly collaborative studies that
may be needed to make further progress in understanding the
genetics of T2D. Alternatively, significant differences may exist
between ethnic groups, such that, the effect size of specific SNPs
may differ between the ethnic groups as a result of differences due
to early development and/or environment. In addition, the
identification of less common SNPs (,5%) may be important
and studies of T2D in ethnic groups would benefit from
sequencing studies.
Supporting Information
Figure S1 Observed 2log P compared to the corre-
sponding power for each of the 54 reported T2D SNPs.
The reference solid line indicates observed P=0.05.
(TIF)
Table S1 Association results of Singapore GWAS for
known T2D loci.
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